2,4-dichloro-5H,6H,7H,8H-pyrido[3,4-d]pyrimidin-8-one
|
D632232-1g
|
≥97% |
2227205-78-7 |
1g
|
¥ 7682.9
|
期货,请咨询 |
阿拉丁 |
4-(tert-butoxycarbonylamino)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxylic acid
|
P635339-5g
|
≥97% |
956460-96-1 |
5g
|
¥ 6532.9
|
期货,请咨询 |
阿拉丁 |
4-(tert-butoxycarbonylamino)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxylic acid
|
P635339-10g
|
≥97% |
956460-96-1 |
10g
|
¥ 10890.9
|
期货,请咨询 |
阿拉丁 |
2,4-dichloro-5H,6H,7H,8H-pyrido[3,4-d]pyrimidin-8-one
|
D632232-100mg
|
≥97% |
2227205-78-7 |
100mg
|
¥ 1601.9
|
期货,请咨询 |
阿拉丁 |
4-(tert-butoxycarbonylamino)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxylic acid
|
P635339-500mg
|
≥97% |
956460-96-1 |
500mg
|
¥ 1522.9
|
期货,请咨询 |
阿拉丁 |
2,4-dichloro-5H,6H,7H,8H-pyrido[3,4-d]pyrimidin-8-one
|
D632232-250mg
|
≥97% |
2227205-78-7 |
250mg
|
¥ 2558.9
|
期货,请咨询 |
阿拉丁 |
4-(tert-butoxycarbonylamino)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxylic acid
|
P635339-250mg
|
≥97% |
956460-96-1 |
250mg
|
¥ 1087.9
|
期货,请咨询 |
阿拉丁 |
7-表-紫杉醇(紫杉醇杂质III)
|
100927
|
供HPLC法系统适用性试验用 |
105454-04-4 |
20mg/支
|
¥ 260.0
|
2周 |
中检所 |
异辛烷/甲苯中7种多氯联苯混合溶液
|
P117624-1ml
|
in Isooctane |
N/A |
1ml
|
¥ 514.9
|
现货 |
阿拉丁 |
AK-7,中枢活性SIRT2抑制剂
|
A274824-100mg
|
≥98% |
420831-40-9 |
100mg
|
¥ 3743.9
|
现货 |
阿拉丁 |
AK-7,中枢活性SIRT2抑制剂
|
A274824-5mg
|
≥98% |
420831-40-9 |
5mg
|
¥ 352.9
|
现货 |
阿拉丁 |
AK-7,中枢活性SIRT2抑制剂
|
A274824-25mg
|
≥98% |
420831-40-9 |
25mg
|
¥ 944.9
|
现货 |
阿拉丁 |
AK-7,中枢活性SIRT2抑制剂
|
A274824-50mg
|
≥98% |
420831-40-9 |
50mg
|
¥ 2090.9
|
现货 |
阿拉丁 |
4-((5,6,7,8-四氢苯并[4,5]噻吩并[2,3-d]嘧啶-4-基)氨基)苯酚
|
R190951-50mg
|
95% |
345615-74-9 |
50mg
|
¥ 1430.0
|
5~7个工作日 |
罗恩 |
4-((5,6,7,8-四氢苯并[4,5]噻吩并[2,3-d]嘧啶-4-基)氨基)苯酚
|
R190951-250mg
|
95% |
345615-74-9 |
250mg
|
¥ 4132.0
|
5~7个工作日 |
罗恩 |
4-((5,6,7,8-四氢苯并[4,5]噻吩并[2,3-d]嘧啶-4-基)氨基)苯酚
|
R190951-100mg
|
95% |
345615-74-9 |
100mg
|
¥ 2431.0
|
5~7个工作日 |
罗恩 |
2,4-二氯-5H,6H,7H,8H-吡啶[3,4-d]嘧啶盐酸盐
|
D172385-1g
|
≥97% |
1187830-76-7 |
1g
|
¥ 397.9
|
期货,请咨询 |
阿拉丁 |
{4-氯-5H,6H,7H-吡咯并[3,4-d]嘧啶-6-基}膦酰二氯
|
C171462-1g
|
≥97% |
N/A |
1g
|
¥ 36.9
|
期货,请咨询 |
阿拉丁 |
7,8-二氢-1H-噻吩并[3,2-D]嘧啶-2,4(3H,6H)-二酮
|
R151147-100mg
|
95% |
87466-56-6 |
100mg
|
¥ 2337.0
|
5~7个工作日 |
罗恩 |
7,8-二氢-1H-噻吩并[3,2-D]嘧啶-2,4(3H,6H)-二酮
|
R151147-250mg
|
95% |
87466-56-6 |
250mg
|
¥ 4284.0
|
5~7个工作日 |
罗恩 |
4-((5,6,7,8-四氢苯并[4,5]噻吩并[2,3-d]嘧啶-4-基)氨基)苯酚
|
R190951-25mg
|
95% |
345615-74-9 |
25mg
|
¥ 842.0
|
5~7个工作日 |
罗恩 |
5-乙酸乙酰氨基-4,7,8-三-O-乙酰基-9-叠氮-3,5,9-三脱氧-2-S-苯基-2-硫-D-丙三氧基-β-D-半乳-2-吡喃壬酮糖甲酯
|
M158561-100mg
|
≥93%(HPLC) |
1195053-25-8 |
100mg
|
¥ 3987.9
|
期货,请咨询 |
阿拉丁 |
5-乙酸乙酰氨基-4,7,8-三-O-乙酰基-9-叠氮-3,5,9-三脱氧-2-S-苯基-2-硫-D-丙三氧基-β-D-半乳-2-吡喃壬酮糖甲酯
|
M158561-10mg
|
≥93%(HPLC) |
1195053-25-8 |
10mg
|
¥ 520.9
|
期货,请咨询 |
阿拉丁 |
5-乙酸乙酰氨基-4,7,8-三-O-乙酰基-9-叠氮-3,5,9-三脱氧-2-S-苯基-2-硫-D-丙三氧基-β-D-半乳-2-吡喃壬酮糖甲酯
|
R111374-10mg
|
≥93% |
1195053-25-8 |
10mg
|
¥ 500.0
|
5~7个工作日 |
罗恩 |